Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 674

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 674
---
 Upon initial recognition, the Group recognizes a liability at the present value of the balance of future lease payments (these payments do not include certain variable lease payments), and concurrently recognizes a right -of -useasset at the same amount of the lease liability, adjusted for any prepaid or accrued lease payments or provision for impairment, plus initial direct costs incurred in respect of the lease. The lease term is the non -cancellableperiod of the lease, plus periods covered by an extension or termination option if it is reasonably certain that the lessee will or will not exercise the option, respectively. Since the interest rate implicit in the Group’s lease is not readily determinable, which involves a management’s estimations, the incremental borrowing rate of the lessee is used. Subsequent to initial recognition, the right -of -useasset is accounted for using the cost model and amortized over the shorter of the lease term or useful life of the asset. 2.8Inventories Inventories include materials, supplies or other assets held for consumption for producing the Group’s services, specifically for processing biological samples to generate test results.

F-133 Notes to Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 2.Summary of significant accounting policies and basis of preparation (cont.) Inventories are measured at the lower of acquisition cost or net realizable value. Inventories are presented net of the allowances for obsolescence, if any. 2.9Cash and cash equivalents Cash and cash equivalents include cash on hand and in banks and short -termhighly liquid investments with original maturities of three months or less, which are readily convertible to known amounts of cash. 2.10 Trade and other receivables with third and related parties, net The counterparty to the receivables generated within the Heritas Diagnostics segment is its shareholder CIBIC, due to a commercialization partnership agreement. See Note 2.4 — Revenue Recognition and Note 20 — Related parties for details. The Group receives payment directly from customers within the Rewell segment. See Note 9 — Trade and other receivables. Trade receivables are carried at amortized cost. Other receivables include tax credits, prepaid expenses and guarantee deposits. Tax credits included under other receivables are assessed for impairment at each reporting period. When the recoverable value of these tax credits is lower than their amortized cost, the Group recognizes an impairment loss. The impairment is recorded as a reduction in the carrying amount of the tax credits, with